Inhibition of the extracellular signal-regulated kinase signaling pathway is correlated with proteasome inhibitor suppression of coxsackievirus replication
Department of Pathology and Laboratory Medicine, University of British Columbia - Vancouver, Vancouver, British Columbia, Canada Biochemical and Biophysical Research Communications
(Impact Factor: 2.3).
08/2007; 358(3):903-7. DOI: 10.1016/j.bbrc.2007.05.013
The ubiquitin/proteasome system (UPS), a major intracellular protein degradation pathway, plays a critical role in coxsackieviral replication. To elucidate the mechanisms by which the UPS regulates viral replication, we studied the influence of proteasome inhibition on signaling through the extracellular signal-regulated kinase (ERK) pathway, a pathway which has been previously demonstrated to be necessary for coxsackieviral replication and contribute to virus-mediated pathogenesis. We found that proteasome inhibition reduced coxsackievirus-induced ERK phosphorylation in a dose-dependent manner, which is correlated with an induction of the mitogen-activated protein kinase phosphatase-1 (MKP-1). Blockade of MKP induction by short-interfering RNA attenuated the loss of ERK phosphorylation, and subsequently restored viral replication. Our results suggest that inhibition of the ERK signaling pathway contributes, as least in part, to proteasome inhibitor-mediated reduction of coxsackievirus replication, demonstrating a converging function of major intracellular signaling and protein degradation pathways in the regulation of viral replication.
- "Inhibition of proteasome activity was shown to impair coxsackievirus B3 replication (Luo et al., 2003). A recent report indicated that coxsackievirus-induced activation of the extracellular signal-regulated kinase (ERK) pathway, which is required for its replication (Luo et al., 2002), is reduced following proteasome inhibition (Wong et al., 2007), suggesting a possible mechanism of proteasome action. The ubiquitin–proteasome pathway also appears to be a critical factor in the lifecycle of HIV, as well. "
[Show abstract] [Hide abstract]
ABSTRACT: The lifecycle of intracellular pathogens, especially viruses, is intimately tied to the macromolecular synthetic processes of their host cell. In the case of positive-stranded RNA viruses, the ability to translate and, thus, replicate their infecting genome is dependent upon hijacking host proteins. To identify proteins that participate in West Nile virus (WNV) replication, we tested the ability of siRNAs designed to knock-down the expression of a large subset of human genes to interfere with replication of WNV replicons. Here we report that multiple siRNAs for proteasome subunits interfered with WNV genome amplification. Specificity of the interference was shown by demonstrating that silencing proteasome subunits did not interfere with Venezuelan equine encephalitis virus replicons. Drugs that blocked proteasome activity were potent inhibitors of WNV genome amplification even if cells were treated 12 h after infection, indicating that the proteasome is required at a post-entry stage(s) of the WNV infection cycle.
Available from: circle.ubc.ca
[Show abstract] [Hide abstract]
ABSTRACT: The morphology of Al2O3 has been modified for use in the commerical SCR process as a support of V2O5/Al2O3 catalyst. A test program for accelerated deactivation at 400°C and continuous deactivation at 250°C has been developed for four kinds of V2O5/Al2O3 catalysts containing the distinctive pore size distributions of Al2O3. The program reveals that both the pore size and the surface area of the catalyst are important for the deactivation of V2O5/Al2O3 catalyst by SO2 to remove NO by NH3. This suggests that a high surface area catalyst with a large mean pore may be an ideal catalyst tolerable to catalyst deactivation by SO2 for SCR reaction. The deactivating agents formed on the catalyst surface confirmed by TGA, XPS and BET analysis of the deactivated catalysts may be Al2(SO4)3 and NH4Al(SO4)2 at 400°C, and NH4Al(SO4)2, NH4HSO4 and (NH4)2SO4 at 250°C.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.